CLINICAL_TRIALS ClinicalTrials.gov record update

Use of Glycerol Phenylbutyrate (Ravicti™) as a Chaperone to Stabilize Enzyme in Patients With MCAD Deficiency Due to the Common MCAD 985A>G (K304E) Mutation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01881984
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:48.250020+00:00
Published At: 2017-07-11T00:00:00+00:00
Record Updated At: 2017-09-25
Results Posted At: 2017-07-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-09-25"
protocolSection.identificationModule.nctId: "NCT01881984"
protocolSection.identificationModule.officialTitle: "Use of Glycerol Phenylbutyrate (Ravicti\u2122) as a Chaperone to Stabilize Enzyme in Patients With MCAD Deficiency Due to the Common MCAD 985A\u003eG (K304E) Mutation"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-07-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.